Business Wire (Thu, 19-Mar 5:00 PM ET)
Analysts Offer Insights on Healthcare Companies: AptarGroup (ATR) and HeartFlow, Inc. (HTFL)
TipRanks (Thu, 19-Mar 8:07 AM ET)
DBS Sticks to Its Buy Rating for AptarGroup (ATR)
TipRanks (Thu, 19-Mar 8:05 AM ET)
AptarGroup Announces CEO Succession and Leadership Transition Plan
TipRanks (Tue, 17-Mar 5:53 PM ET)
Business Wire (Tue, 17-Mar 5:11 PM ET)
Aptar appoints Gael Touya as CEO
Seeking Alpha News (Tue, 17-Mar 5:09 PM ET)
Business Wire (Mon, 16-Mar 5:00 PM ET)
Aptar to Participate in Upcoming Investor Conferences
Business Wire (Wed, 18-Feb 5:00 PM ET)
Aptar Reports Fourth Quarter and Annual 2025 Results
Business Wire (Thu, 5-Feb 5:00 PM ET)
Aptar Declares Quarterly Dividend and Announces 2026 Annual Meeting Details
Business Wire (Thu, 22-Jan 5:00 PM ET)
Headquartered in Crystal Lake, Illinois, AptarGroup is a leading global supplier of dispensing systems such as aerosol valves, pumps, closures, and elastomer packaging components to the consumer goods and pharmaceutical markets. Its sales are primarily from Europe (49% of sales) and the United States (28%), with China contributing 5% and other countries contributing 17%. It operates three business segments, Pharma, Beauty, and Closures. Pharma generates over two thirds of group profits.
Aptargroup trades on the NYSE stock market under the symbol ATR.
As of March 20, 2026, ATR stock price declined to $121.26 with 517,292 million shares trading.
ATR has a beta of 0.62, meaning it tends to be less sensitive to market movements. ATR has a correlation of 0.17 to the broad based SPY ETF.
ATR has a market cap of $7.81 billion. This is considered a Mid Cap stock.
Last quarter Aptargroup reported $963 million in Revenue and $1.25 earnings per share. This beat revenue expectation by $77 million and exceeded earnings estimates by $.02.
In the last 3 years, ATR traded as high as $178.03 and as low as $103.23.
The top ETF exchange traded funds that ATR belongs to (by Net Assets): VTI, IJH, VB, VBR, VXF.
ATR has underperformed the market in the last year with a price return of -16.2% while the SPY ETF gained +15.6%. However, in the short term, ATR had mixed performance relative to the market. It has outperformed in the last 3 months, returning +0.3% vs -4.7% return in SPY. But in the last 2 weeks, ATR shares have been beat by the market, returning -10.0% compared to an SPY return of -4.8%.
ATR support price is $121.69 and resistance is $126.26 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ATR shares will trade within this expected range on the day.